Related Experiment Videos
Recurrent rupture of a mycotic ascending aortic aneurysm: a surgical and medical challenge
1Clinic for Cardiovascular Surgery, University Hospital, Zurich, Switzerland.
Abstract:
Infection in the vascular tree remains one of the greatest challenges for vascular surgeons. Despite technical advances and newer antibiotics, the morbidity and mortality remain high. The following case report underlines the complex factors encountered in a 62-year-old alcoholic patient presenting with a "classical" history of mycotic aneurysmal disease who suffered from recurrent rupture of the aneurysm of the ascending aorta. In situ reconstruction of the ascending aorta was performed with patch of xenopericardium. As demonstrated in this case, aggressive surgical management and long-term triple antibiotic therapy can salvage patients even with multiple complications in the early postoperative period.
Insights
Mycotic aneurysms, particularly in the ascending aorta, pose significant risks. Aggressive surgical repair combined with prolonged antibiotic therapy offers a life-saving option for patients with complex vascular infections.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Cardiovascular Medicine
Background:
- Vascular tree infections present a persistent challenge for vascular surgeons.
- High morbidity and mortality rates persist despite advancements in surgical techniques and antibiotics.
Observation:
- A 62-year-old alcoholic patient presented with a history of mycotic aneurysmal disease.
- The patient experienced recurrent rupture of an ascending aorta aneurysm.
Findings:
- In situ reconstruction of the ascending aorta was successfully performed using a xenopericardium patch.
- The patient's complex case involved multiple early postoperative complications.
Implications:
- Aggressive surgical management is crucial for treating complex mycotic aneurysms.
- Long-term triple antibiotic therapy is vital for patient salvage.
- This case highlights the potential for successful outcomes even in high-risk patients.